You are here

CERID Bibliography

Export 34 results:
Author Title [ Type(Desc)] Year
Filters: Author is Kain, Kevin C  [Clear All Filters]
Journal Article
Wolofsky KT, Ayi K, Branch DR, Hult AK, Olsson ML, W Liles C, Cserti-Gazdewich CM, Kain KC. ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes. PLoS Pathog. 2012 ;8(10):e1002942.
Ayi K, W Liles C, Gros P, Kain KC. Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro. J Infect Dis. 2009 ;200(8):1289-99.
Ricciuto DR, Santos CC dos, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011 ;39(4):702-10.
Patel SN, Berghout J, Lovegrove FE, Ayi K, Conroy A, Serghides L, Min-Oo G, D Gowda C, J Sarma V, Rittirsch D, et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med. 2008 ;205(5):1133-43.
Conroy A, Serghides L, Finney C, Owino SO, Kumar S, D Gowda C, W Liles C, Moore JM, Kain KC. C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS One. 2009 ;4(3):e4953.
Hawkes M, Li X, Crockett M, Diassiti A, Finney C, Min-Oo G, W Liles C, Liu J, Kain KC. CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect Dis. 2010 ;10:299.
Erdman LK, Dhabangi A, Musoke C, Conroy AL, Hawkes M, Higgins S, Rajwans N, Wolofsky KT, Streiner DL, W Liles C, et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One. 2011 ;6(2):e17440.
Conroy AL, McDonald CR, Silver KL, W Liles C, Kain KC. Complement activation: a critical mediator of adverse fetal outcomes in placental malaria?. Trends Parasitol. 2011 ;27(7):294-9.
Finney CAM, Lu Z, Hawkes M, Yeh W-C, W Liles C, Kain KC. Divergent roles of IRAK4-mediated innate immune responses in two experimental models of severe malaria. Am J Trop Med Hyg. 2010 ;83(1):69-74.
Page AV, Tarr PI, Watkins SL, Rajwans N, Petruzziello-Pellegrini TN, Marsden PA, Kain KC, W Liles C. Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome. J Infect Dis. 2013 ;208(6):929-33.
Kim H, Higgins S, W Liles C, Kain KC. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol. 2011 ;18(3):177-85.
Lovegrove FE, Gharib SA, Patel SN, Hawkes CA, Kain KC, W Liles C. Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol. 2007 ;171(6):1894-903.
Helmers AJ, Lovegrove FE, Harlan JM, Kain KC, W Liles C. Failure of two distinct anti-apoptotic approaches to reduce mortality in experimental cerebral malaria. Am J Trop Med Hyg. 2008 ;79(6):823-5.
Wang F, Lu Z, Hawkes M, Yang H, Kain KC, W Liles C. Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages. J Inflamm (Lond). 2010 ;7:30.
Higgins SJ, Kain KC, W Liles C. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti Infect Ther. 2011 ;9(9):803-19.
Erdman LK, Finney CAM, W Liles C, Kain KC. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity. Mol Biochem Parasitol. 2008 ;162(2):105-11.
Hawkes M, Opoka RO, Namasopo S, Miller C, Thorpe KE, Lavery JV, Conroy AL, W Liles C, John CC, Kain KC. Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials. 2011 ;12:176.
Serghides L, Kim H, Lu Z, Kain DC, Miller C, Francis RC, W Liles C, Zapol WM, Kain KC. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One. 2011 ;6(11):e27714.
Darwish I, Miller C, Kain KC, W Liles C. Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza. Int J Med Sci. 2012 ;9(2):157-62.
Hawkes M, Li X, Crockett M, Diassiti A, W Liles C, Liu J, Kain KC. Malaria exacerbates experimental mycobacterial infection in vitro and in vivo. Microbes Infect. 2010 ;12(11):864-74.
Darwish I, Banner D, Mubareka S, Kim H, Besla R, Kelvin DJ, Kain KC, W Liles C. Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza. PLoS One. 2013 ;8(8):e71761.
Hawkes M, Opoka ROpika, Namasopo S, Miller C, Conroy AL, Serghides L, Kim H, Thampi N, W Liles C, John CC, et al. Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale. Med Hypotheses. 2011 ;77(3):437-44.
Lovegrove FE, Gharib SA, Peña-Castillo L, Patel SN, Ruzinski JT, Hughes TR, W Liles C, Kain KC. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 2008 ;4(5):e1000068.
Conroy AL, W Liles C, Molyneux ME, Rogerson SJ, Kain KC. Performance characteristics of combinations of host biomarkers to identify women with occult placental malaria: a case-control study from Malawi. PLoS One. 2011 ;6(12):e28540.
Lovegrove FE, Peña-Castillo L, W Liles C, Hughes TR, Kain KC. Plasmodium falciparum shows transcriptional versatility within the human host. Trends Parasitol. 2008 ;24(7):288-91.

Pages